Abstract:Oral bacteria speak a sophisticated glycolanguage transmitted through versatile glycoinfrastructure, carbohydrate‐active enzymes, and lectins, which contributes decisively to their success in the oral habitat. Deciphering this glycolanguage opens new avenues for novel antibacterials to treat oral diseases. The oral cavity harbors a diverse and dynamic bacterial biofilm community which is pivotal to oral health maintenance and, if turning dysbiotic, can contribute to various diseases. Glycans as unsurpassed carriers of biological information are participating in underlying processes that shape oral health and disease. Bacterial glycoinfrastructure—encompassing compounds as diverse as glycoproteins, lipopolysaccharides (LPSs), cell wall glycopolymers, and exopolysaccharides—is well known to influence bacterial fitness, with direct effects on bacterial physiology, immunogenicity, lifestyle, and interaction and colonization capabilities. Thus, understanding oral bacterias' glycoinfrastructure and encoded glycolanguage is key to elucidating their pathogenicity mechanisms and developing targeted strategies for therapeutic intervention. Driven by their known immunological role, most research in oral glycobiology has been directed onto LPSs, whereas, recently, glycoproteins have been gaining increased interest. This review draws a multifaceted picture of the glycolanguage, with a focus on glycoproteins, manifested in prominent oral bacteria, such as streptococci, Porphyromonas gingivalis, Tannerella forsythia, and Fusobacterium nucleatum. We first define the characteristics of the different glycoconjugate classes and then summarize the current status of knowledge of the structural diversity of glycoconjugates produced by oral bacteria, describe governing biosynthetic pathways, and list biological roles of these energetically costly compounds. Additionally, we highlight emerging research on the unraveling impact of oral glycoinfrastructure on dental caries, periodontitis, and systemic conditions. By integrating current knowledge and identifying knowledge gaps, this review underscores the importance of studying the glycolanguage oral bacteria speak to advance our understanding of oral microbiology and develop novel antimicrobials.

How Sweet Are Our Gut Beneficial Bacteria? A Focus on Protein Glycosylation in Lactobacillus

Protein glycosylation: Sweet or bitter for bacterial pathogens?

Sweet complexity: O-linked protein glycosylation in pathogenic Neisseria

Glycan utilisation system in Bacteroides and Bifidobacteria and their roles in gut stability and health

Molecular Insights Into O-Linked Glycan Utilization by Gut Microbes

Probiotic Gut Microbiota Isolate Interacts with Dendritic Cells via Glycosylated Heterotrimeric Pili

The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease

The role of mucin O-glycans in microbiota dysbiosis, intestinal homeostasis, and host-pathogen interactions

N -acyl glycines produced by commensal bacteria potentiate GLP-1 secretion as GPCR ligands

The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system

Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria

Vertebrate protein glycosylation: diversity, synthesis and function

Role of Protein Glycosylation in Host-Pathogen Interaction

Glycolanguage of the oral microbiota

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

Re-framing the importance of Group B Streptococcus as a gut-resident pathobiont

The Genomic Basis of Lactobacilli as Health-Promoting Organisms

Looking into key bacterial proteins involved in gut dysbiosis

[Protein glycosylation in bacterial and viral infections]

Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows

Role of Protein Glycosylation in Interactions of Medically Relevant Fungi with the Host